Chemotaxis overrides the killing response in alloreactive CTLs, providing vascular immune privilege during cellular rejection.
Chemotaxis may play a critical role in preserving graft vasculature during T cell-mediated rejection, suggesting a shift in understanding immune privilege mechanisms.
Where it sits
this study against the rest of the fgl (fg loop peptide) corpusSummary and findings
This study investigates the mechanisms of vascular immune privilege during T cell-mediated rejection (TCMR) in graft endothelial cells (ECs). It employs transcriptomics and coculture experiments to assess the susceptibility of ECs and epithelial cells to cytotoxic T lymphocytes (CTLs) and examines chemotactic gradients in murine kidney grafts. The findings suggest that chemotaxis plays a significant role in preserving graft vasculature.
Abstract
Graft endothelial cells (ECs) express donor alloantigens and encounter cytotoxic T lymphocytes (CTLs) but are generally spared during T cell-mediated rejection (TCMR), which predominantly affects epithelial structures. The mechanisms underlying this vascular immune privilege are unclear. Transcriptomics analyses and endothelial-mesenchymal transition assessments confirmed that the graft endothelium was preserved during TCMR. Coculture experiments revealed that endothelial and epithelial cells were equally susceptible to CTL-mediated lysis, ruling out cell-intrinsic protection. Intravital microscopy of murine kidney grafts and single-cell RNA-Seq of human renal allografts demonstrated that CTL interactions with ECs were transient compared with epithelial cells. This disparity was mediated by a chemotactic gradient produced by graft stromal cells, guiding CTLs away from ECs toward epithelial targets. In vitro, chemotaxis overrode T cell receptor-induced cytotoxicity, preventing endothelial damage. Finally, analysis of TCMR biopsies revealed that disruption of the chemotactic gradient correlated with endothelialitis lesions, linking its loss to vascular damage. These findings challenge the traditional view of cell-intrinsic immune privilege, proposing a cell-extrinsic mechanism, in which chemotaxis preserves graft vasculature during TCMR. This mechanism may have implications beyond transplantation, highlighting its role in maintaining vascular integrity across pathological conditions.
Background
The paper addresses the biological question of how chemotaxis influences the behavior of alloreactive CTLs during cellular rejection. Prior studies have indicated that CTLs play a critical role in mediating rejection, but the mechanisms by which chemotaxis affects their function are not fully understood. This study is significant as it explores the potential for chemotaxis to alter the expected cytotoxic response of CTLs, which could have implications for transplant immunology.
Methods
Not reported in abstract.
Results
Not reported in abstract.
Interpretation
Not reported in abstract.
Key findings
- Not reported in abstract.
- Not reported in abstract.
- Not reported in abstract.
Limitations
- Not reported in abstract.